Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/humrep/deaa220 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum: Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease.
Front Neurol
January 2025
Department of Neurology, University of California, Irvine, Irvine, CA, United States.
[This corrects the article DOI: 10.3389/fneur.2024.
View Article and Find Full Text PDFCorrigendum to "Insights into molecular interactions at organic-MBene heterointerfaces for efficient Zn-ion storage" [J. Coll. Inter. Sci. 678(Part B) (2025) 95-104/ YJCIS_35740].
J Colloid Interface Sci
January 2025
School of Electronic and Information Engineering, Hebei University of Technology, Tianjin 300130, China; Hebei Collaborative Innovation Center of Microelectronic Materials and Technology in Ultra Precision Processing, Tianjin 300130, China; Hebei Engineering Research Center of Microelectronic Materials and Devices, Tianjin 300130, China.
Corrigendum to "Home infusion experience in patients with Pompe disease receiving avalglucosidase alfa during three clinical trials" [Molecular Genetics and Metabolism, 143 (2024) 108608].
Mol Genet Metab
January 2025
Center for Lysosomal and Metabolic Diseases, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
Corrigendum to "Surface modification of rare earth Sm-doped WO films through polydopamine for enhanced electrochromic energy storage performance" [J. Colloid Interface Sci. 649 (2023) 510-518].
J Colloid Interface Sci
December 2024
Engineering Research Center for Hydrogen Energy Materials and Devices, College of Rare Earths, Jiangxi University of Science and Technology, 86 Hong Qi Road, Ganzhou 341000, PR China. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!